Vita Oklander
Medical · Brooklyn, NYNPI 1932343894
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 421 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 39 manufacturers reported payments, led by Novo Nordisk at 26.6% of the total. Among medical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 421 payments — averaging $31.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$4K
- Dexcom, Inc.$1K
- AbbVie$875
- AstraZeneca$840
- Corcept Therapeutics$826
- Amneal Pharmaceuticals LLC$748
- plus $5K from 33 others
What the payments were for
- Food & beverage$13,388100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 71 | $3,563 |
| Dexcom, Inc. | 12 | $1,096 |
| AbbVie | 38 | $875 |
| AstraZeneca(2 entities) | 31 | $840 |
| Corcept Therapeutics | 24 | $826 |
| Amneal Pharmaceuticals LLC | 33 | $748 |
| Lilly USA, LLC | 26 | $721 |
| Novartis | 37 | $661 |
| Bayer | 10 | $574 |
| Intuity Medical Inc | 10 | $442 |
| Intra-sana Laboratories | 7 | $387 |
| Boehringer Ingelheim | 18 | $380 |
| Ironwood Pharmaceuticals, Inc | 18 | $373 |
| Sanofi-aventis U.S. LLC | 13 | $293 |
| Amryt Pharma Holdings Ltd | 6 | $160 |
| Cequr Corporation | 4 | $146 |
| Xeris Pharmaceuticals, Inc. | 7 | $142 |
| Nestle Healthcare Nutrition Inc. | 6 | $127 |
| Amgen | 5 | $107 |
| Arbor Pharmaceuticals, Inc. | 5 | $104 |
| Currax Pharmaceuticals LLC | 6 | $94 |
| Insulet Corporation | 4 | $80 |
| Amarin Pharma, Inc. | 4 | $73 |
| Tandem Diabetes Care, Inc. | 3 | $62 |
| Vistapharm, Inc. | 3 | $60 |
| Chiesi USA, Inc. | 2 | $56 |
| Ardelyx, Inc. | 2 | $53 |
| Kyowa Kirin, Inc. | 2 | $46 |
| Abbott | 2 | $44 |
| Zealand Pharma US, Inc. | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Aimmune Therapeutics, Inc. | 1 | $34 |
| Abiomed | 1 | $27 |
| Theracosbio, LLC | 1 | $24 |
| Vivus LLC | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Lifescan, Inc. | 1 | $20 |
| Merck | 1 | $18 |
| Boston Scientific | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$1,529
- DEXCOM G7 GSS (161)$683
- Ozempic$582
- DEXCOM STELO GLUCOSE BIOSENSOR$433
- Kerendia$375
- Reltone 200 Mg$293
- GLYCATE$293
- Reltone 400 Mg$293
- DEXCOM G6 TRANSMITTER$250
- Pogo Automatic Blood Glucose Monitoring System$234
- FARXIGA$125
- MOUNJARO$125
- Korlym$125
- LEQVIO$105
How this compares
$13,388 in reported general payments places this provider in the 95th percentile of 2,395 medical providers in New York.
Other medical in Brooklyn
- Carl ClarkeBrooklyn$116K
- Catherine SekanskyBrooklyn$28K
- Phillip ScottiBrooklyn$22K
- Anna GorelikBrooklyn$15K
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.